Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than Clarithromycin

1992 ◽  
Vol 166 (2) ◽  
pp. 405-412 ◽  
Author(s):  
R. J. Wallace ◽  
B. A. Brown ◽  
G. O. Onyi
Keyword(s):  
Soft Tissue ◽  
Corticosteroid Therapy ◽  
Mycobacterium Chelonae ◽  
Bone Infections

Skin, soft tissue and bone infections

2021 ◽  
pp. 245-248
Author(s):  
Mary Peirse ◽  
Aula Abbara
Keyword(s):  
Soft Tissue ◽  
Bone Infections

Mycobacterium chelonae subspecies abscessus soft-tissue infection following plastic surgery

1995 ◽  
Vol 17 (5) ◽  
pp. 39-40 ◽  
Author(s):  
M.I. Campos-Herrero ◽  
A. Bordes ◽  
M.C. Ruiz ◽  
A. Perera ◽  
J. Fernández ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Plastic Surgery ◽  
Soft Tissue Infection ◽  
Tissue Infection ◽  
Mycobacterium Chelonae

Sulbactam/Ampicillin versus Cefotaxime as Initial Therapy in Serious Soft Tissue, Joint and Bone Infections

Drugs ◽  
1988 ◽  
Vol 35 (Supplement 7) ◽  
pp. 46-52 ◽  
Author(s):  
L. Löffler ◽  
A. Bauernfeind ◽  
W. Keyl
Keyword(s):  
Soft Tissue ◽  
Initial Therapy ◽  
Bone Infections

Local antibiotic treatment of soft tissue and bone infections of the foot

1990 ◽  
Vol 80 (7) ◽  
pp. 345-353 ◽  
Author(s):  
DE Stabile ◽  
AM Jacobs
Keyword(s):  
Soft Tissue ◽  
Bone Cement ◽  
Success Rate ◽  
Polymethyl Methacrylate ◽  
Antibiotic Treatment ◽  
Soft Tissue Infection ◽  
Definitive Diagnosis ◽  
Histologic Examination ◽  
Bone Infections ◽  
Local Antibiotic

Twenty-seven pedal soft tissue and bone infections in 26 patients were treated with surgical necrectomy of infected tissues and implantation of antibiotic-loaded polymethyl methacrylate bone cement beads on chains. The definitive diagnosis of the infected tissues was obtained by culture and histologic examination in all of the cases. A wide variety of foot infections was successfully treated in this manner. The success rate without recurrence of osteomyelitis or soft tissue infection was 95% in this study at an average of 16 months after surgery.

scholarly journals Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection

2018 ◽  
Vol 5 (7) ◽  
Author(s):  
Khalid M Dousa ◽  
Ahmed Babiker ◽  
Daniel Van Aartsen ◽  
Neel Shah ◽  
Robert A Bonomo ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Tyrosine Kinase ◽  
B Cell ◽  
Soft Tissue Infection ◽  
Opportunistic Infections ◽  
Tissue Infection ◽  
Irreversible Inhibitor ◽  
B Cell Malignancies ◽  
Mycobacterium Chelonae ◽  
First Case

Abstract Ibrutinib is an irreversible inhibitor of Bruton’s tyrosine kinase approved for the treatment of B-cell malignancies. There is growing concern about the risk of opportunistic infections following ibrutinib therapy. Herein, we describe the first case of Mycobacterium chelonae skin and soft tissue infection in a patient receiving ibrutinib and recount the challenges in treating this infection.

Therapy of Skin, Soft Tissue, and Bone Infections with Cefoxitin Sodium

1979 ◽  
Vol 1 (1) ◽  
pp. 165-169 ◽  
Author(s):  
R. L. Perkins ◽  
T. G. Slama ◽  
R. J. Fass ◽  
R. B. Prior ◽  
J. F. Plouffe ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Bone Infections
Sign in / Sign up

Export Citation Format

Share Document